Cargando…

Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic

BACKGROUND: The COVID-19 pandemic has placed excessive strain on health care systems and is especially evident in treatment decision-making for cancer patients. Glioblastoma (GBM) patients are among the most vulnerable due to increased incidence in the elderly and the short survival time. A virtual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gatson, Na Tosha N., Barnholtz-Sloan, Jill, Drappatz, Jan, Henriksson, Roger, Hottinger, Andreas F., Hinoul, Piet, Kruchko, Carol, Puduvalli, Vinay K., Tran, David D., Wong, Eric T., Glas, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139188/ https://www.ncbi.nlm.nih.gov/pubmed/34026655 http://dx.doi.org/10.3389/fonc.2021.679702

Ejemplares similares

COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE
por: Tosha Gatson, Na, et al.
Publicado: (2020)

A comparison of relative survival and cause‐specific survival methods to measure net survival in cancer populations
por: Makkar, Nupur, et al.
Publicado: (2018)

BSCI-06. FREQUENCY OF BRAIN METASTASIS FROM BREAST AND LUNG CANCER IN THE UNITED STATES -- A POPULATION-BASED ASSESSMENT
por: Ostrom, Quinn, et al.
Publicado: (2019)

COVD-14. TELEMEDICINE REVIEW IN NEURO-ONCOLOGY: COMPARATIVE EXPERIENTIAL ANALYSIS FOR BARROW NEUROLOGICAL INSTITUTE AND GEISINGER HEALTH DURING THE 2020 COVID-19 PANDEMIC
por: Fonkem, Ekokobe, et al.
Publicado: (2020)

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)

Sex Differences in Time to Treat and Outcomes for Gliomas
por: Stabellini, Nickolas, et al.
Publicado: (2021)

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021)

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022)

Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex
por: Thierheimer, Marisa, et al.
Publicado: (2023)

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
por: Lacouture, Mario E., et al.
Publicado: (2020)

Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017
por: Cioffi, Gino, et al.
Publicado: (2022)

IL-2 TUMOR TREATING FIELDS: IMPROVING THE ODDS FOR PATIENTS WITH GLIOBLASTOMA
por: Hottinger, Andreas F
Publicado: (2022)

Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database
por: Hodges, Tiffany R, et al.
Publicado: (2021)

MDB-18. MOLECULARLY-DEFINED MEDULLOBLASTOMA: POPULATION-LEVEL PATTERNS IN THE UNITED STATES, 2018-2019
por: Ostrom, Quinn T, et al.
Publicado: (2023)

Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009
por: de Blank, Peter M, et al.
Publicado: (2015)

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
por: Fabian, Denise, et al.
Publicado: (2019)

The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2–3 meningioma across the lifespan
por: Walsh, Kyle M, et al.
Publicado: (2023)

Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023)

Immunotherapy associated central nervous system complications in primary brain tumors
por: Mantica, Megan, et al.
Publicado: (2023)

Epidemiology of vestibular schwannoma in the United States, 2004–2016
por: Cioffi, Gino, et al.
Publicado: (2020)

Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study
por: Malay, Sindhoosha, et al.
Publicado: (2020)

Tumor microenvironment in glioblastoma: Current and emerging concepts
por: Sharma, Pratibha, et al.
Publicado: (2023)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide
por: Robins, H. Ian, et al.
Publicado: (2018)

Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
por: Palmer, Joshua D., et al.
Publicado: (2021)

Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis
por: Du, Xue, et al.
Publicado: (2022)

Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
por: Vymazal, Josef, et al.
Publicado: (2023)

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
por: Gittleman, Haley, et al.
Publicado: (2019)

Epidemiology of Brain and Other CNS Tumors
por: Ostrom, Quinn T., et al.
Publicado: (2021)

Standards of care and novel approaches in the management of glioblastoma multiforme
por: Hottinger, Andreas F., et al.
Publicado: (2014)

An evaluation of MGMT promoter methylation within the methylation subclasses of glioblastoma
por: Alnahhas, Iyad, et al.
Publicado: (2020)

Identification of Variants in Primary and Recurrent Glioblastoma Using a Cancer-Specific Gene Panel and Whole Exome Sequencing
por: Virk, Selene M., et al.
Publicado: (2015)

Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy
por: Li, Taoran, et al.
Publicado: (2018)

Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
por: Miller, Ryan, et al.
Publicado: (2022)

Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry
por: Chien, Li-Nien, et al.
Publicado: (2016)

Tumor treating fields: a novel treatment modality and its use in brain tumors
por: Hottinger, Andreas F., et al.
Publicado: (2016)

Secondary Normal-Pressure Hydrocephalus in Rheumatoid Meningitis
por: Owens, Micaela, et al.
Publicado: (2021)

Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010
por: Gittleman, Haley R, et al.
Publicado: (2015)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

Immunotherapy in Glioblastoma: A Clinical Perspective
por: Desbaillets, Nicolas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6qsi1k8qels998jtpnj50m459g